Probucol increases cholesteryl ester transfer protein activity in hypercholesterolaemic patients
Probucol, a widely used lipid lowering drug, reduces both low- and high-density (LDL and HDL) lipoprotein levels and can induce a regression of tissue lipid deposits in both animals and man.
G. Franceschini +3 more
core +1 more source
International audienceSubnormal plasma levels of high-density lipoprotein cholesterol (HDL-C) constitute a major cardiovascular risk factor; raising low HDL-C levels may therefore reduce the residual cardiovascular risk that frequently presents in ...
Kontush, Anatol +3 more
core +1 more source
Total Synthesis and Stereochemical Assignment of the Quinquecyclopropane-Containing Cholesteryl Ester Transfer Protein Inhibitor U ...
Anthony G. M. Barrett (1707928) +3 more
core +1 more source
Cholesteryl ester transfer protein inhibition is associated with reduced risk of Sjögren's syndrome. [PDF]
Zhao SS, Dyball S.
europepmc +1 more source
Phospholipids that Plug the Pores of Cholesteryl Ester Transfer Protein Control Its Triglyceride Transfer. [PDF]
Sacher S +8 more
europepmc +1 more source
Cholesteryl ester storage disease-a rare case of elevated liver enzymes and cholesterol levels with similarities to familial hypercholesterolaemia: a case report. [PDF]
Martinsen MH +3 more
europepmc +1 more source
Roles of peripheral lipoproteins and cholesteryl ester transfer protein in the vascular contributions to cognitive impairment and dementia. [PDF]
Poliakova T, Wellington CL.
europepmc +1 more source
Hepatic Steatosis: A Presentation of Cholesteryl Ester Storage Disease. [PDF]
Lee A +5 more
europepmc +1 more source
From Failure to Promise: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition in Atherosclerotic Cardiovascular Disease. [PDF]
Prajapathi S +3 more
europepmc +1 more source
Structure-based mechanism and inhibition of cholesteryl ester transfer protein. [PDF]
Xue H, Zhang M, Liu J, Wang J, Ren G.
europepmc +1 more source

